Description:
Tenofovir Alafenamide 25 mg Tablets is an antiviral medication used for the treatment of chronic Hepatitis B virus (HBV) infection in adults with compensated liver disease. It belongs to the class of nucleotide reverse transcriptase inhibitors (NRTIs) and offers potent antiviral activity with improved renal and bone safety compared to earlier formulations.
Therapeutic Use:
Treatment of chronic HBV infection in adults with stable liver function (compensated liver disease)
Mechanism of Action:
Tenofovir Alafenamide (TAF) is a prodrug of tenofovir that, once activated in the body, inhibits the HBV DNA polymerase enzyme, thereby preventing viral replication. It helps to reduce the amount of HBV in the body and lowers the risk of liver damage.
Dosage Form:
Tablet
Strength:
25 mg
Prescription Status:
Prescription-only medication. To be used under the supervision of a qualified healthcare professional.
Packaging:
Typically available in blister or bottle packaging, with configurations as per regulatory and market requirements.
Note:
Regular monitoring of liver function and viral load is recommended during therapy. This medication is not a cure for hepatitis B but plays a key role in controlling the infection and preventing disease progression.
Would you like this formatted for a hospital supply catalog or export documentation?
